Involvement of NF-κB-mediated expression of galectin-3- binding protein in TNF-α-induced breast cancer cell adhesion

Oncology Reports

Volumn 27, Issue 6, 2012, Pages 2080-2084

  Noma, Naruto ^a   Simizu, Siro ^a   Kambayashi, Yusuke ^a   Kabe, Yasuaki ^a   Suematsu, Makoto ^a   Umezawa, Kazuo ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Adhesion; Breast cancer; Galectin 3 binding protein; NF B

Indexed keywords

BINDING PROTEIN; FIBRONECTIN; GALECTIN 3 BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL ADHESION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANTIGENS, NEOPLASM; BENZAMIDES; BREAST NEOPLASMS; CARRIER PROTEINS; CELL ADHESION; CELL LINE, TUMOR; CYCLOHEXANONES; FEMALE; GLYCOPROTEINS; HUMANS; NF-KAPPA B; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84860744578     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1733     Document Type: Article

References (30)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
2. Warner E: Breast-cancer screening. N Engl J Med 365: 1025-1032, 2011.
3. Drabsch Y and Dijke PT: TGF-β signaling in breast cancer cell invasion and bone metastasis. J Mammary Gland Biol Neoplasia 16: 97-108, 2011.
4. Galvão E, Martins LMS, Ibiapina JO, Andrade HM and Monte SJH: Breast cancer proteomics: a review for clinicians. J Cancer Res Clin Oncol 137: 915-925, 2011.
5. Ellis MJ, Hayes DF and Lippman ME: Treatment of metastatic breast cancer. In: Diseases of the Breast. Harris J, Lippman M, Morrow M and Osborne CK (eds). 3rd edition. Lippincott Williams & Wilkins, Philadelphia, pp1101-1162, 2004.
6. Moore S and Cobleigh MA: Targeting metastatic and advanced breast cancer. Semin Oncol Nurs 23: 37-45, 2007.
7. Sen R and Baltimore D: Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705-716, 1986. (Pubitemid 16020062)
8. Ghosh S, May MJ and Kopp EB: NF-κB and REL proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225-260, 1998. (Pubitemid 28183365)
9. Prasad S, Ravindran J and Aggarwal BB: NF-κB and cancer: how intimate is this relationship. Mol Cell Biochem 336: 25-37, 2010.
10. Matsumoto N, Ariga A, To-e S, et al: Synthesis of NF-κB activation inhibitors derived from epoxyquinomycin C. Bioorg Med Chem Lett 10: 865-869, 2000. (Pubitemid 30301582)
11. Suzuki Y, Sugiyama C, Ohno O and Umezawa K: Preparation and biological activities of optically active dehydroxymethylepoxyquinomycin, a novel NF-κB inhibitor. Tetrahedron 60: 7060-7066, 2004.
12. Ariga A, Namekawa J, Matsumoto N, Inoue J and Umezawa K: Inhibition of tumor necrosis factor-α-induced nuclear translocation and activation of NF-κB by dehydroxymethylepoxyquinomicin. J Biol Chem 277: 24625-24630, 2002. (Pubitemid 34951991)
13. Yamamoto M, Horie R, Takeiri M, Kozawa I and Umezawa K: Inactivation of NF-κB components by covalent binding of (-)-dehydroxymethylepoxyquinomicin to specific cysteine residues. J Med Chem 51: 5780-5788, 2008.
14. Umezawa K: Inhibition of tumor growth by NF-κB inhibitors. Cancer Sci 97: 990-995, 2006.
15. Iacobelli S, Arno E, D'Orazio A and Coletti G: Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer. Cancer Res 46: 3005-3010, 1986. (Pubitemid 16074320)
16. Hellstern S, Sasaki T, Fauser C, Lustig A, Timpl R and Engel J: Functional studies on recombinant domains of Mac-2 binding protein. J Biol Chem 277: 15690-15696, 2002. (Pubitemid 34967842)
17. Linsley PS, Horn D, Marquardt H, et al: Identification of a novel serum protein secreted by lung carcinoma cells. Biochemistry 25: 2978-2986, 1986. (Pubitemid 16073835)
18. Koths K, Taylor E, Helenbeck R, Casipit C and Wang A: Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain. J Biol Chem 268: 14245-14249, 1993. (Pubitemid 23195548)
19. Fusco O, Querzoli P, Nenci I, et al: 90K (Mac-2 BP) gene expression in breast cancer and evidence for the production 90K by peripheral blood mononuclear cells. Int J Cancer 79: 23-26, 1998. (Pubitemid 28157721)
20. Künzli BM, Berberat PO, Zhu ZW, et al: Influences of the lysosomal associated membrane proteins (Lamp-1, Lamp-2) and mac-2 binding protein (Mac-2-BP) on the prognosis of pancreatic carcinoma. Cancer 94: 228-239, 2002. (Pubitemid 34049063)
21. Ozaki Y, Kontani K, Hanaoka J, et al: Expression and immunogenicity of a tumor-associated antigen, 90K/Mac-2 binding protein, in lung carcinoma. Cancer 95: 1954-1962, 2002.
22. Iacobelli S, Sismondi P, Giai M, et al: Prognostic value of a novel circulating serum 90K antigen in breast cancer. Br J Cancer 69: 172-176, 1994. (Pubitemid 24021843)
23. Marchetti A, Tinari N, Buttitta F, et al: Expression of 90K (Mac- BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients. Cancer Res 62: 2535-2539, 2002. (Pubitemid 34462731)
24. Sasaki T, Brakebusch C, Engel J and Timpl R: Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds β1 integrins, collagens and fibronectin. EMBO J 17: 1606-1613, 1998. (Pubitemid 28119114)
25. Wang L, Zhou X, Zhou T, et al: Ecto-5′-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells. Cancer Res Clin Oncol 134: 365-372, 2008. (Pubitemid 351170058)
26. van der Saag PT, Caldenhoven E and van de Stolpe A: Molecular mechanisms of steroid action: a novel type of cross-talk between glucocorticoids and NF-kappa B transcription factors. Eur Respir J Suppl 22: 1465s-1535s, 1996.
27. Iademarco MF, McQuillan JJ, Rosen GD and Dean DC: Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 267: 16323-16329, 1992.
28. Whelan J, Ghersa P, van Huijsduijnen RH, et al: An NF kappa B-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Nucleic Acids Res 19: 2645-2653, 1991. (Pubitemid 21896900)
29. Burridge K and Chrzanowska-Wodnicka M: Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol 12: 463-519, 1996. (Pubitemid 26422722)
30. Han S, Khuri FR and Roman J: Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/ mammalian target of rapamycin/S6 kinase and inactivation LKB/AMP-activated protein kinase signal pathways. Cancer Res 66: 315-323, 2006. (Pubitemid 43166038)